Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Volatility of index funds for retirement can be managed through thoughtful allocation, rebalancing, and a long-term perspective.
23,516 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Tether holds roughly 154 metric tons of bullion valued around $20 billion, with a growing role in crypto lending as i...
As July 29 approaches, investors eye Microsoft’s Q4 results for a potential breakout. This article lays out why the s...
What if one cryptocurrency could outgrow Bitcoin and Ethereum combined? This article dives into the drivers, risks, a...
Could SpaceX go public and spark a 450% rally? A wall street analyst sees big upside if key growth engines and regula...
Oracle stock down 60% from its peak doesn’t tell the whole story. This article digs into the AI cloud momentum fuelin...
SpaceX is hovering around its $135 IPO price as investors digest post-debut dynamics. One broker, Raymond James, argu...
Oracle shares have fallen sharply as investors reassess AI-related capital expenditure. This piece compares Oracle’s ...
Tariff refunds total about $71 billion by June, yet inflationary pressure from the Iran conflict muffles the relief a...
As AI accelerates, Greg Abel is steering Berkshire Hathaway Energy to prepare for higher data-center electricity dema...
A widening gap between data-center demand and supply is boosting heavy equipment and power-management stocks. Discove...
Bridgewater's trio of tech giants—Amazon, Alphabet, and NVIDIA—anchor the investment firm's AI-focused bets. This art...